Jean-Jacques Patard

TL;DR: These guidelines contain information for the treatment of an individual patient according to a current standardised general approach and can improve the clinical handling of patients with RCC.

TL;DR: Among patients with locoregional clear-cell renal-cell carcinoma at high risk for tumor recurrence after nephrectomy, the median duration of disease-free survival was significantly longer in the sunitinib group than in the placebo group, at a cost of a higher rate of toxic events.

TL;DR: This guideline is designed to help urologists assess the evidence-based management of RCC and to incorporate the guideline recommendations into their clinical practice.

TL;DR: The level of tumor thrombus in the IVC does not significantly affect long-term overall survival in patients with renal cell carcinoma, and this has to be considered for the next revision of the TNM system.

TL;DR: The objective of the current study was to compare the discriminating accuracy of four prognostic models developed to predict the survival of patients undergoing nephrectomy for nonmetastatic renal cell carcinoma (RCC).